Litela Participacoes S.A. (LTLA3BF) Quote

More accurately, it is inappropriate to publicly fund that final stage. Biotechs and pharma, no matter how big or small, pay to have their drug evaluated for commercialization (the NDA only), and for good reasons. In economic terms it's called incentive alignment. You want companies making rational

His family certainly isn’t as evident by this 2018 post by his daughter.

The Orange blob (215 LBS LOL) is a lifelong cheat at everything.



https://t.co/v0OWDtP74n

I don't?

It’s not hard to spot an IHUB newbie trying to pump an acknowledged garbage stock like GRCU.

They are a dime a dozen these days.

Buyer beware.

Well all I can say is Mark G posted the same on his PERSONAL Twitter and I responded back with that message.
---
Lets see
Here you go
https://x.com/MarkGaalswyk/status/1847754215675810160
--
EZBOSS = MG
(was not surprising to me, that is how he

" Alzheimer's Society News" Blarcamesine among the "Three promising drugs for treating Alzheimer's disease bring fresh hope".

The drug "Blarcamesine" is also being tested for other conditions, including Parkinson’s disease dementia

Information for the new investor.

Would what they are doing now

Shareholders post

Stop this nonsense. We are tired of your negativity!!!

The stock is going up CRAZY!!!

ENOUGH!!!!

Anyone call

Wonder if this goes up

Terrible 😢 what happened here

Neat drink design

I think I can safely say it got Phase V past the statute of limitations point.

Made off this a while back

Terrible what happened here

1,5,11,45

Good Luck Everyone!

Interesting company

Neat drink design

Interesting

Apparently he's jealous of KBLB. In ao many ways! Lol

Of course he does!

Investors need to realize $YUKA is NEW, new management, and a completely new direction. The CEO is Jessica Miller, she moved its domicile from Florida to Colorado and sent a notification to FINRA for a Name change to Med Holdings Group and a new Symbol to coincide with the new name. She also hired a